New treatment options for aesthetic indications are in record-high demand, fueled by an aging population, and a growing focus on aesthetic issues related to nutritional habits, sedentary lifestyles, the complex stresses of 21st-century life and rising awareness about aesthetic solutions in all adult age groups. The search for more effective, less invasive, more affordable and safer solutions is more intense than ever.
Development of drugs and devices in the aesthetic realm has evolved significantly. Still, a key question remains: How to create and implement a superior aesthetic development program in the shortest time possible and on a reasonable budget?
This webinar will lead participants through key strategic, operational and regulatory considerations that will drive program optimization. By the end of the webinar, viewers will be equipped to dive deeper into their aesthetic program, regardless of its stage.
Nach Davé, RPh. MSc, Vice President, Development Strategy, Premier Research
Nach Davé provides strategic and commercial input for Premier Research’s business activities. He brings more than 20 years of experience in the pharmaceutical and contract research industries to the position. He previously served as the vice president of regulatory at Premier and has been in leadership positions at both CROs and sponsor companies.
In his current role, Davé brings innovative solutions and grows Premier’s footprint in the areas of medical device development, real-world evidence, and government relations. He is keen to explore how innovative technology like AI, ML, and other developments can best support the growth of Premier’s business.
Mr. Davé holds a master’s degree in drug regulatory affairs from Long Island University and a bachelor’s degree in pharmacy from the University of Sciences-Philadelphia. He is a registered pharmacist.Message Presenter
Jasmina Jankicevic, MD, Vice President, Medical Affairs, Dermatology and Medical Aesthetics, Premier Research
Dr. Jasmina Jankicevic works with pharmaceutical, biotechnology, medical device and cosmetic companies to drive clinical development, medical affairs and successful commercialization of innovative dermatologic and medical aesthetics solutions.
As a clinician, researcher, teacher and industry leader, Dr. Jankicevic has dedicated 20 years to innovation and optimization of therapeutic paradigms for more than 30 skin disorders including psoriasis, acne, rosacea, atopic dermatitis, skin and nail infections, wounds, hair loss, pigmentary disorders, autoimmune bullous dermatoses, genodermatoses, connective tissue diseases, photodamage, actinic keratosis and skin cancers. She has successfully led clinical development programs and medical strategy in several companies including Premier Research, Allergan, Leo Pharma, and Murad.
Dr. Jankicevic is a trained dermatologist, and scientist, certified clinical research professional, trained journalist, published author and sought-after speaker. She holds Medical Degree, Master of Medical Sciences Degree and Board-Certification in Dermatology and Venereology from University of Belgrade, Serbia.Message Presenter
Marlis Sarkany, MD, Senior Medical Director, Premier Research
Marlis Sarkany has over 30 years of experience in phase 1 to phase 4 global clinical development in dermato-oncology, aesthetic dermatology, acne, rosacea, onychomycosis and orphan skin diseases and over 6 years of experience in the global clinical development of medical devices, including photodynamic therapy and hyaluronic acid fillers.Message Presenter
Who Should Attend?
Managers and above at biotech and specialty pharma companies with job functions including but not limited to:
- Clinical Operations
- Medical Affairs
- Project Management
- Regulatory Affairs
What You Will Learn
In this webinar, participants will learn about:
- Recognizing aesthetic market segmentation and trends
- Defining a well-targeted patient population
- Securing the highest-quality study data using key measures
- Understanding the regulatory framework for product safety and efficacy
Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.